SCHEMBL6325352

SCHEMBL6325352

CN(C)c1nccc(C(=O)O)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.55
ALDH1A1 P00352 5/20 0.55
KDM5A P29375 2/20 0.50
KDM3A Q9Y4C1 2/20 0.50
JMJD1C Q15652 1/20 0.50
HPGD P15428 2/20 0.49
ALOX15 P16050 3/20 0.47
HSD17B10 Q99714 2/20 0.47
LMNA P02545 3/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
TSHR P16473 2/20 0.45
ACMSD Q8TDX5 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
KDM6B O15054 1/20 0.42
TET3 O43151 1/20 0.42
KDM4A O75164 1/20 0.42
BBOX1 O75936 1/20 0.42
MAPT P10636 1/20 0.42
KDM5C P41229 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12609250 0.84 ALDH1A1 (0.44) KDM4EALDH1A1KDM5AKDM3AJMJD1C
SCHEMBL6650242 0.82 KDM4E (0.42) KDM4EALDH1A1KDM5AKDM3AJMJD1C
SCHEMBL29825918 0.80 KDM4E (0.47) KDM4EALDH1A1KDM5AKDM3AJMJD1C
SCHEMBL1790483 0.79 MAPK1 (0.43) KDM4EALDH1A1KDM3AHPGDALOX15
SCHEMBL26555468 0.79 HPGD (0.41) KDM4EALDH1A1HPGDALOX15HSD17B10
SCHEMBL7214552 0.79 TDP1 (0.51) KDM4EALDH1A1KDM5AKDM3AJMJD1C
SCHEMBL6981215 0.79 HRH3 (0.45) KDM4EALDH1A1KDM5AKDM3AJMJD1C
SCHEMBL3560191 0.77 KDM4E (0.55) KDM4EALDH1A1KDM5AKDM3AJMJD1C
SCHEMBL30740854 0.76 JAK3 (0.50) KDM4EALDH1A1KDM5AKDM3AJMJD1C
SCHEMBL27955600 0.75 CYP1A2 (0.57) KDM4EALDH1A1HPGDHSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116285775-A High-performance chloroprene rubber adhesive and preparation method thereof 上谷新材料(苏州)有限公司 2023-06-23 CN claimed
CN-116102700-A Softening agent and preparation method thereof 江苏奥斯佳材料科技股份有限公司 2023-05-12 CN claimed
CN-112961303-B Softening agent for soft polyurethane foam and application thereof 江苏奥斯佳材料科技股份有限公司 2023-01-03 CN claimed
CN-112961303-A Softening agent for soft polyurethane foam and application thereof 江苏奥斯佳材料科技股份有限公司 2021-06-15 CN claimed
CN-112940212-A Polyurethane catalyst, automotive polyurethane material and preparation method thereof 江苏奥斯佳材料科技股份有限公司 2021-06-11 CN claimed
CN-104558467-B A kind of catalysts for polyurethanes and its application 江苏奥斯佳材料科技有限公司 2018-02-23 CN claimed
CN-104558468-B A kind of application of catalysts for polyurethanes in hard polyurethane material is synthesized 江苏奥斯佳材料科技有限公司 2018-02-23 CN claimed
CN-104558469-B A kind of application of catalysts for polyurethanes in flexible polyurethane foam is synthesized 江苏奥斯佳材料科技有限公司 2018-02-23 CN claimed
CN-104558469-A Application of polyurethane catalyst in synthesis of flexible polyurethane foamed plastic JIANGSU AOSIJIA MATERIAL SCIENCE & TECHNOLOGY CO LTD 2015-04-29 CN claimed
CN-104558467-A Polyurethane catalyst and application thereof JIANGSU AOSIJIA MATERIAL SCIENCE & TECHNOLOGY CO LTD 2015-04-29 CN claimed
CN-104558468-A Application of polyurethane catalyst in synthesis of rigid polyurethane material JIANGSU AOSIJIA MATERIAL SCIENCE & TECHNOLOGY CO LTD 2015-04-29 CN claimed
CN-117043154-A GPCR receptor agonists, pharmaceutical compositions comprising same, and methods of use thereof 卡莫特医疗有限公司 2023-11-10 CN disclosed
CN-116285775-A High-performance chloroprene rubber adhesive and preparation method thereof 上谷新材料(苏州)有限公司 2023-06-23 CN disclosed
CN-116120515-A Flexible polyurethane foam and method for producing the same 江苏奥斯佳材料科技股份有限公司 2023-05-16 CN disclosed
CN-116102700-A Softening agent and preparation method thereof 江苏奥斯佳材料科技股份有限公司 2023-05-12 CN disclosed
US-8507485-B2 Cyclic compound having pyrimidinylalkylthio group SANTEN PHARMACEUTICAL CO., LTD. (JP) 2013-08-13 US disclosed
US-20110124646-A1 Novel cyclic compound having pyrimidinylalkylthio group SANTEN PHARMACEUTICAL CO., LTD. (JP) 2011-05-26 US disclosed
CN-101080396-A Quinoxalines as B Raf inhibitors ASTRAZENECA AB (SE) 2007-11-28 CN disclosed
US-6867210-B2 Aryl substituted pyrimidines EURO-CELTIQUE S.A. (LU) 2005-03-15 US disclosed
US-20050043305-A1 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof EURO-CELTIQUE S.A. (LU) 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043305-A1 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof CACNA1S, CACNA1C, KYNU KDM4E 2686/4885ALDH1A1 226/4885KDM5A 793/4885
US-20110124646-A1 Novel cyclic compound having pyrimidinylalkylthio group FLT1, VEGFA, FLT4 KDM4E 3990/4885ALDH1A1 185/4885KDM5A 4083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.